Literature DB >> 11347671

First cases of acute human granulocytic ehrlichiosis in Poland.

S Tylewska-Wierzbanowska1, T Chmielewski, M Kondrusik, T Hermanowska-Szpakowicz, W Sawicki, K Sułek.   

Abstract

The first three cases of acute human granulocytic ehrlichiosis in Poland are described. Blood samples were tested by an indirect immunofluorescence method to detect specific serum antibodies, and the polymerase chain reaction was used to detect ehrlichial DNA. Additionally, peripheral blood smears were examined for the presence of morulae. According to criteria of the Centers for Disease Control and Prevention, all three cases can be classified as confirmed granulocytic ehrlichiosis. Using the criteria recommended by a consensus group, however, two cases can be classified as confirmed granulocytic ehrlichiosis and one case as probable granulocytic ehrlichiosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347671     DOI: 10.1007/s100960100464

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Identification of Borrelia burgdorferi sensu lato, Anaplasma and Ehrlichia species, and spotted fever group Rickettsiae in ticks from Southeastern Europe.

Authors:  I Christova; J Van De Pol; S Yazar; E Velo; L Schouls
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

2.  First documented case of human granulocytic ehrlichiosis in Austria.

Authors:  Gernot Walder; Barbara Falkensammer; Johannes Aigner; Gerhard Tiwald; Manfred P Dierich; Reinhard Würzner; Peter Lechleitner
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

3.  High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany.

Authors:  Friederike D von Loewenich; Birgit U Baumgarten; Klaus Schröppel; Walter Geissdörfer; Martin Röllinghoff; Christian Bogdan
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

4.  Divergence within the marker region of the groESL operon in Anaplasma phagocytophilum.

Authors:  A Rymaszewska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-13       Impact factor: 3.267

5.  First described case of human granulocytic anaplasmosis in a patient in Eastern Austria.

Authors:  Ursula Maria Vogl; Elisabeth Presterl; Gerold Stanek; Michael Ramharter; Klaus-Bernhard Gattringer; Wolfgang Graninger
Journal:  Wien Med Wochenschr       Date:  2010-02

Review 6.  Ixodes ricinus and Its Transmitted Pathogens in Urban and Peri-Urban Areas in Europe: New Hazards and Relevance for Public Health.

Authors:  Annapaola Rizzoli; Cornelia Silaghi; Anna Obiegala; Ivo Rudolf; Zdeněk Hubálek; Gábor Földvári; Olivier Plantard; Muriel Vayssier-Taussat; Sarah Bonnet; Eva Spitalská; Mária Kazimírová
Journal:  Front Public Health       Date:  2014-12-01

7.  Detection and quantification of Anaplasma phagocytophilum and Babesia spp. in Ixodes ricinus ticks from urban and rural environment, northern Poland, by real-time polymerase chain reaction.

Authors:  Joanna Stańczak; Stella Cieniuch; Anna Lass; Beata Biernat; Maria Racewicz
Journal:  Exp Appl Acarol       Date:  2015-02-27       Impact factor: 2.132

8.  Human granulocytic anaplasmosis in Kinmen, an offshore island of Taiwan.

Authors:  Kun-Hsien Tsai; Lo-Hsuan Chung; Chia-Hao Chien; Yu-Jung Tung; Hsin-Yi Wei; Tsai-Ying Yen; Pei-Yun Shu; Hsi-Chieh Wang
Journal:  PLoS Negl Trop Dis       Date:  2019-09-20

9.  Babesia spp. and Anaplasma phagocytophilum in questing ticks, ticks parasitizing rodents and the parasitized rodents--analyzing the host-pathogen-vector interface in a metropolitan area.

Authors:  Cornelia Silaghi; Dietlinde Woll; Dietmar Hamel; Kurt Pfister; Monia Mahling; Martin Pfeffer
Journal:  Parasit Vectors       Date:  2012-09-05       Impact factor: 3.876

Review 10.  Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.

Authors:  Rachael J Thomas; J Stephen Dumler; Jason A Carlyon
Journal:  Expert Rev Anti Infect Ther       Date:  2009-08       Impact factor: 5.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.